{"title":"Asthma & COPD - SMi's sixth annual conference.","authors":"Saloni Shah","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>SMi's sixth annual conference on Asthma & COPD, held in London, included topics covering new therapeutic developments in the field of asthma and COPD. This conference report highlights selected presentations on understanding these diseases; bronchodilators and corticosteroids, both of which remain a mainstay in asthma therapy; new developments in COPD therapy; PI3K inhibitors as a new treatment approach for asthma and COPD; and oligonucleotides, particularly DNAzyme therapy for asthma.</p>","PeriodicalId":55031,"journal":{"name":"Idrugs","volume":"13 6","pages":"376-8"},"PeriodicalIF":0.0000,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idrugs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
SMi's sixth annual conference on Asthma & COPD, held in London, included topics covering new therapeutic developments in the field of asthma and COPD. This conference report highlights selected presentations on understanding these diseases; bronchodilators and corticosteroids, both of which remain a mainstay in asthma therapy; new developments in COPD therapy; PI3K inhibitors as a new treatment approach for asthma and COPD; and oligonucleotides, particularly DNAzyme therapy for asthma.